Aldeyra Therapeutics (ALDX) Debt Ratio (2013 - 2026)

Aldeyra Therapeutics' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.23 for Q1 2026.

• Quarterly Debt Ratio rose 42.05% year-over-year to 0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.23 (up 42.05% YoY) and the FY2025 annual result came in at 0.42, up 192.14% from the prior year.
• Debt Ratio was 0.23 for Q1 2026 at Aldeyra Therapeutics, down from 0.42 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.42 in Q4 2025 and bottomed at 0.07 in Q1 2022.
• A 5-year average of 0.16 and a median of 0.12 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio tumbled 50.62% — and 2025, when it soared 198.03%.
• Aldeyra Therapeutics' Debt Ratio stood at 0.09 in 2022, then increased by 16.91% to 0.1 in 2023, then soared by 40.72% to 0.14 in 2024, then jumped by 192.14% to 0.42 in 2025, then plunged by 45.18% to 0.23 in 2026.
• Business Quant data shows ALDX's Debt Ratio at 0.23 in Q1 2026, 0.42 in Q4 2025, and 0.39 in Q3 2025.